Answers are grounded in this paper and cite their sources.
Objective: Prognostic assessment in older patients with metastatic colon cancer remains challenging. This study aimed to evaluate the associations of clinicopathological characteristics, computed tomography (CT)-defined low skeletal muscle mass, and inflammatory–nutritional indices with overall survival (OS) and progression-free survival (PFS). Methods: This single-center study analyzed data from 141 patients aged ≥65 years who received first-line systemic therapy between 2020 and 2026. Skeletal muscle index was evaluated in 128 patients using pretreatment CT images. Survival outcomes were assessed using Kaplan–Meier analysis and multivariable Cox proportional hazards regression analysis. Results: The median age was 71 years, and 75.0% of evaluable patients had a low skeletal muscle mass. The median OS was 30.32 months (95% confidence interval [CI]: 26.60–34.05), while the median PFS was 10.28 months (95% CI: 8.59–11.98). Synchronous metastases (hazard ratio [HR] = 3.745), Grade 3 tumors (HR = 3.084), absence of metastasectomy (HR = 3.650), high Köhne risk (HR = 2.546) and elevated carbonhydrate antigen [CA19-9] levels (HR = 1.812) were independently associated with shorter OS. Body mass index (BMI) of ≥25 kg/m2 was associated with a lower risk of mortality (HR = 0.624). High Köhne risk (HR = 2.162), Grade 3 tumors (HR = 1.750), elevated carcinoembryonic antigen [CEA] levels (HR = 1.716) and elevated CA19-9 levels (HR = 1.579) were independently associated with shorter PFS. No statistically significant difference was found between low skeletal muscle mass and survival. Furthermore, none of the inflammatory–nutritional indices included in the key multivariable models maintained their independent prognostic significance. Conclusions: High Köhne risk, poor tumor differentiation, and elevated CA19-9 levels were independently associated with shorter OS and PFS in older patients with metastatic colon cancer. There was no statistically significant difference between low skeletal muscle mass and survival outcomes, while inflammatory–nutritional indices did not show independent prognostic significance in the key multivariable models. Further prospective studies involving larger patient populations are needed to confirm these results.
No takes yet. Share an insight, caveat, or question.
Yetim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: